Active Ingredient History
Cannabis is a genus of flowering plants in the family Cannabaceae. The number of species within the genus is disputed. Three species may be recognized: Cannabis sativa, C. indica, and C. ruderalis. Alternatively, C. ruderalis may be included within C. sativa, all three may be treated as subspecies of C. sativa, or C. sativa may be accepted as a single undivided species. The genus is widely accepted as being indigenous to and originating from Asia. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Pain (Phase 3)
Adolescent (Phase 2)
Affect (Phase 2)
Aging (Phase 2)
Alcohol Drinking (Phase 1)
Alcohol-Induced Disorders (Phase 1)
Alcoholism (Early Phase 1)
Amyotrophic Lateral Sclerosis (Phase 2/Phase 3)
Analgesics, Opioid (Phase 1)
Anemia, Sickle Cell (Phase 2)
Anxiety (Phase 2)
Arthritis, Psoriatic (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Autistic Disorder (Phase 2)
Automobile Driving (Phase 2)
Back Pain (Phase 3)
Bipolar Disorder (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Cannabidiol (Phase 2)
Cannabis (Phase 3)
Chronic Pain (Phase 2)
Chronic Traumatic Encephalopathy (Phase 2)
Cognitive Dysfunction (Phase 2)
Colitis, Ulcerative (Phase 2)
Constipation (Phase 1)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Crohn Disease (Phase 2)
Depression (Phase 2)
Depressive Disorder, Major (Phase 2)
Diabetic Neuropathies (Phase 2)
Diagnosis, Dual (Psychiatry) (Phase 1)
Driving Under the Influence (Phase 1)
Dronabinol (Phase 2)
Drug Interactions (Phase 1)
Drug Resistant Epilepsy (Phase 3)
Dyspnea (Phase 2)
Electromyography (Phase 2/Phase 3)
Epilepsy (Phase 2)
Exercise (Phase 2)
Feeding and Eating Disorders (Phase 3)
Fibromyalgia (Phase 2)
Gastrointestinal Diseases (Phase 1)
Glaucoma (Phase 2)
Glioblastoma (Phase 1)
Healthy Volunteers (Phase 1)
Heart Disease Risk Factors (Early Phase 1)
Hepatitis C (Phase 2)
Hidradenitis Suppurativa (Phase 2)
HIV (Phase 2)
HIV Infections (Phase 2)
Hyperalgesia (Phase 2)
Hypotension (Phase 1)
Inflammatory Bowel Diseases (Phase 2)
Low Back Pain (Phase 2)
Lung Neoplasms (Phase 1)
Marijuana Abuse (Phase 2)
Marijuana Smoking (Phase 2)
Marijuana Use (Phase 2)
Migraine Disorders (Phase 2)
Motor Neuron Disease (Phase 2/Phase 3)
Multiple Sclerosis (Phase 3)
Muscle Spasticity (Phase 3)
Myofascial Pain Syndromes (Phase 2/Phase 3)
Nausea (Phase 2)
Neck Pain (Phase 3)
Neoplasms (Phase 3)
Neuralgia (Phase 2)
Neuralgia, Postherpetic (Phase 1/Phase 2)
Nicotine (Phase 1)
Obsessive-Compulsive Disorder (Phase 1/Phase 2)
Opiate Overdose (Phase 2)
Opioid-Related Disorders (Phase 2)
Osteoarthritis, Knee (Phase 2)
Pain (Phase 3)
Pain Threshold (Phase 2)
Parkinson Disease (Phase 2)
Peripheral Nervous System Diseases (Phase 1/Phase 2)
Pharmacology (Phase 1)
Phobia, Social (Phase 2)
Protein-Energy Malnutrition (Phase 3)
Psoriasis (Phase 1)
Psychotic Disorders (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Reflex Sympathetic Dystrophy (Phase 1/Phase 2)
Renal Dialysis (Phase 3)
Retinal Degeneration (Early Phase 1)
Retinitis Pigmentosa (Early Phase 1)
Schizophrenia (Phase 1)
Seizures (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Sleep Disorders, Intrinsic (Phase 2)
Sleep Wake Disorders (Phase 2)
Smoking (Early Phase 1)
Spinal Cord Diseases (Phase 2/Phase 3)
Spinal Cord Injuries (Phase 2/Phase 3)
Stress Disorders, Post-Traumatic (Phase 2)
Substance-Related Disorders (Phase 1)
Tachycardia (Phase 1)
Temporomandibular Joint Disorders (Phase 2/Phase 3)
Tinnitus (Phase 1)
Tobacco Use (Phase 2)
Tourette Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
